HomeCYAD • EBR
Celyad Oncology SA
€0.35
Mar 28, 6:00:00 PM GMT+1 · EUR · EBR · Disclaimer
StockBE listed securityBE headquartered
Previous close
€0.36
Day range
€0.35 - €0.37
Year range
€0.35 - €1.28
Market cap
15.04M EUR
Avg Volume
12.37K
P/E ratio
-
Dividend yield
-
Primary exchange
EBR
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Jun 2023Y/Y change
Revenue
22.00K
Operating expense
2.40M-68.83%
Net income
-1.87M71.16%
Net profit margin
-8.50K
Earnings per share
EBITDA
-2.27M69.35%
Effective tax rate
Total assets
Total liabilities
(EUR)Jun 2023Y/Y change
Cash and short-term investments
4.98M-65.41%
Total assets
12.18M-80.71%
Total liabilities
11.16M-65.65%
Total equity
1.02M
Shares outstanding
22.59M
Price to book
7.10
Return on assets
-49.35%
Return on capital
-386.49%
Net change in cash
(EUR)Jun 2023Y/Y change
Net income
-1.87M71.16%
Cash from operations
-4.17M
Cash from investing
482.50K
Cash from financing
-51.00K
Net change in cash
-3.73M
Free cash flow
-1.26M
About
Founded
2004
Website
Employees
37
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu